Weight ManagementEmerging ResearchResearch Only

MOTS-c

Also known as: Mitochondrial Open Reading Frame of the 12S rRNA-c, Mitochondrial-Derived Peptide, Exercise Mimetic Peptide

MOTS-c is a 16-amino-acid peptide encoded within the mitochondrial genome (12S rRNA gene), making it one of the few known mitochondrial-derived peptides with systemic signaling functions. Discovered in 2015 by Dr. Changhan Lee's lab at USC, MOTS-c activates the AMPK pathway — the same cellular energy sensor activated by exercise — and has been called an "exercise mimetic" for its ability to reproduce many of the metabolic benefits of physical activity. Research has demonstrated improvements in insulin sensitivity, glucose metabolism, and exercise capacity. MOTS-c levels decline with age, correlating with metabolic dysfunction and reduced physical performance. Supplementation aims to restore youthful metabolic signaling.

Research Score7/10

Growing body of research

Safety Score8/10

Well-tolerated with minimal side effects

How It Works

MOTS-c is encoded by the mitochondrial 12S rRNA gene and acts as a retrograde signaling molecule. It activates AMPK, the master cellular energy sensor, promoting glucose uptake, fatty acid oxidation, and mitochondrial biogenesis. It also translocates to the nucleus under metabolic stress to regulate gene expression related to antioxidant defense and metabolism.

Key Benefits

  • Activates AMPK (the exercise pathway)
  • Improves insulin sensitivity and glucose metabolism
  • Enhances physical endurance and exercise capacity
  • Supports healthy aging and metabolic function
  • May protect against age-related metabolic decline
  • Promotes mitochondrial function

Who May Benefit

  • Adults with age-related metabolic decline or insulin resistance
  • Individuals with limited exercise capacity seeking metabolic support
  • People pursuing longevity and anti-aging protocols
  • Athletes looking to enhance endurance and recovery

Dosage & Administration

Typical Dosage
Daily, before exercise
Cycle Length
8-12 weeks
Administration Routes
subcutaneous

Expected Timeline

Improved energy and exercise tolerance in 2-4 weeks. Metabolic and insulin sensitivity gains at 4-8 weeks. Full benefits over 8-12 week cycle.

Safety Information

Possible Side Effects

Injection site irritationMild headache (rare)Temporary fatigue during initial dosing

Contraindications

Pregnancy or breastfeedingActive malignancyType 1 diabetes (use with caution)Concurrent hypoglycemic medications without medical supervisionMitochondrial diseases
Dr. Patrick Taylor, MD

Dr. Taylor's 2 Cents

MOTS-c is the peptide equivalent of exercise in a bottle — and I don't say that lightly. It activates the exact same AMPK pathway that exercise does, which means improved insulin sensitivity, better glucose metabolism, and enhanced mitochondrial function. I use it for patients who are metabolically compromised or physically limited and need to jumpstart their cellular metabolism. It's not a replacement for exercise, but it can amplify the benefits and help patients who are starting from a deficit.

Discuss with Dr. Taylor →

Frequently Asked Questions

What is MOTS-c?
A 16-amino-acid peptide encoded by mitochondrial DNA that acts as an exercise mimetic by activating the AMPK energy-sensing pathway.
Why is MOTS-c called an exercise mimetic?
It activates the same AMPK pathway that physical exercise does, reproducing many metabolic benefits including improved insulin sensitivity, glucose uptake, and fat oxidation.
How is MOTS-c administered?
Via subcutaneous injection, typically 5-10 mg administered 2-3 times per week.
Does MOTS-c replace exercise?
No — it amplifies the benefits of exercise and supports those who are physically limited, but regular physical activity remains essential for overall health.
Is MOTS-c safe?
MOTS-c is a naturally occurring peptide in human mitochondria. Side effects are generally mild and include injection site irritation and transient headache.
Who discovered MOTS-c?
MOTS-c was discovered in 2015 by Dr. Changhan Lee's research lab at the University of Southern California.

Published Research

1

The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance

Lee C, Zeng J, Drew BG, et al. · Cell Metabolism (2015)

Key Finding: MOTS-c regulated insulin sensitivity and metabolic homeostasis by activating AMPK, preventing age-dependent and high-fat-diet-induced insulin resistance in mice.

2

MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis

Reynolds JC, Lai RW, Woodhead JST, et al. · Nature Communications (2021)

Key Finding: MOTS-c levels increased with exercise and declined with age. Exogenous MOTS-c improved physical capacity, skeletal muscle homeostasis, and genomic integrity in aged mice.

3

Mitochondrial-derived peptides in energy metabolism

Kim SJ, Xiao J, Wan J, Cohen P, Yen K · Annals of the New York Academy of Sciences (2017)

Key Finding: MOTS-c and other mitochondrial-derived peptides function as retrograde signaling molecules from mitochondria to the nucleus, regulating systemic energy metabolism and stress responses.

Want personalized guidance?

Consult with Dr. Patrick Taylor for a comprehensive evaluation and personalized protocol.

Book a Consultation

Medical Disclaimer: This information is for educational purposes only and is not medical advice. Consult a healthcare provider before starting any peptide protocol.